GlassScriptPhysician profile
Ramesh P Kanuru
NPI 1891772281
$1,065.34
in general payments reported to CMS, 2019-2025
16 companies · $88.69 in 2025
The $88.69 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $102 · 2021: $248 · 2022: $208 · 2023: $42.45 · 2024: $101 · 2025: $88.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $293.11 | 2021-2025 | Proclaim |
| Boston Scientific Corporation | $134.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $95.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.61 | 2019-2025 | Relistor, Trulance |
| Cardiovascular Systems INC. | $65.67 | 2019 | |
| Biodelivery Sciences International, INC. | $62.71 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $52.78 | 2021-2025 | Belbuca |
| Depuy Synthes Sales INC. | $50.09 | 2021-2022 | |
| Horizon Therapeutics Plc | $50.08 | 2021 | |
| Myoscience INC. | $47.61 | 2019 | |
| Nalu Medical, INC. | $31.43 | 2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $28.09 | 2019-2020 | |
| Assertio Therapeutics, INC. | $22.68 | 2019 | |
| Valinor Pharma, LLC | $22.45 | 2025 | Movantik |
| Almatica Pharma LLC | $21.12 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Kanuru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.